Youth Cannabis Use Trends: Data, Research, and Public Health Insights

Executive Summary

Youth cannabis use in the United States has reached its lowest level in decades, according to September 2026 data from the Centers for Disease Control and Prevention (CDC), contradicting long-standing predictions that legalization would increase adolescent consumption. The CDC's Youth Risk Behavior Survey (YRBS) shows that current marijuana use among high school students dropped to 15.9% in 2025, down from a peak of 23.1% in 2011. This 31% decline occurred during the same period when 24 states legalized adult-use cannabis and 38 states established medical marijuana programs. The data challenges the gateway theory and provides empirical evidence that regulated markets with age restrictions may be more effective at limiting youth access than prohibition. Public health officials, cannabis policy advocates, and lawmakers are now reassessing decades of drug education policy in light of these findings. The trend has significant implications for ongoing federal rescheduling debates, state legalization campaigns, and the allocation of prevention resources.

Why This Matters

The historic decline in youth cannabis consumption directly impacts 15 million American high school students, reshapes $30 billion in annual state and federal drug prevention spending, and fundamentally challenges the core argument opponents use against legalization. For parents and educators, the data suggests that current prevention strategies—including age-gated retail systems, public education campaigns funded by cannabis tax revenue, and evidence-based school programs—are working better than the zero-tolerance approaches of the 1990s and 2000s. School districts in California, Colorado, and Washington have reported that disciplinary incidents related to cannabis have declined alongside usage rates. For policymakers, the findings remove a primary objection to legalization. Opposition groups including Smart Approaches to Marijuana (SAM) have consistently argued that legal markets would increase adolescent use. The CDC data undermines this position at a critical moment: the Drug Enforcement Administration is reviewing cannabis scheduling under the Controlled Substances Act, and multiple states including Florida, Ohio, and Pennsylvania are considering adult-use legalization in 2026 and 2027. For the cannabis industry, the statistics provide evidence that licensed operators with compliance obligations are better stewards of public health than illicit dealers. Multi-state operators including Curaleaf, Trulieve, and Green Thumb Industries have invested more than $50 million in youth prevention programs since 2020, and these companies now cite the CDC data in regulatory filings and legislative testimony. For researchers and public health professionals, the trend demands explanation. The National Institute on Drug Abuse (NIDA) has allocated $12 million in new grants to study why legalization correlates with decreased youth use, examining factors including reduced stigma that makes teens more honest in surveys, displacement of illicit markets that don't check ID, and the "forbidden fruit" effect where legalization makes cannabis less appealing to adolescents seeking rebellion.

Background and History

Youth cannabis monitoring in the United States began in earnest in 1975 with the launch of the Monitoring the Future (MTF) survey, establishing a 51-year data record that now shows adolescent use declining to levels not seen since the survey's inception.

1975-1990: The First Wave of Data

The University of Michigan's MTF survey, funded by NIDA, first measured youth cannabis use in 1975 when 27% of high school seniors reported past-30-day use. This figure declined steadily through the 1980s as the Reagan administration's "Just Say No" campaign and increased criminal penalties took effect. By 1992, youth use had fallen to 11.9%, the lowest rate ever recorded. During this period, cannabis remained classified as a Schedule I substance under the Controlled Substances Act of 1970 (21 U.S.C. § 812), and no state had legalized medical use.

1996-2010: Medical Marijuana and the Second Peak

California's Proposition 215 in 1996 established the first state medical marijuana program, creating a natural experiment in policy effects. Youth use began climbing in the late 1990s, reaching 21.5% among high school seniors by 1999. Public health officials and law enforcement attributed the increase to "mixed messages" about cannabis safety. By 2011, when 16 states had medical programs, the CDC's YRBS recorded its highest-ever youth use rate: 23.1% of high school students reported past-30-day consumption. The 2011 peak occurred despite—or perhaps because of—widespread Drug Abuse Resistance Education (DARE) programs in schools. A 2009 meta-analysis in the Journal of School Health found that DARE had no significant effect on youth drug use, leading many districts to abandon the curriculum.

2012-2016: Adult-Use Legalization Begins

Colorado and Washington became the first states to legalize adult-use cannabis in November 2012, with retail sales beginning in 2014. Opponents predicted immediate spikes in youth consumption. Kevin Sabet, president of SAM, testified before Congress in 2013 that legalization would "send a message to kids that marijuana is safe" and cause use rates to surge. The opposite occurred. In Colorado, youth past-30-day use declined from 22% in 2011 to 19.4% in 2015, according to the state's Healthy Kids Colorado Survey. Washington saw a similar decline, from 20.4% to 17.8% over the same period. The CDC's national YRBS showed youth use dropping to 21.7% by 2015.

2017-2020: Vaping Crisis and Continued Decline

The 2019 EVALI outbreak (e-cigarette or vaping product use-associated lung injury) temporarily complicated youth cannabis trends. The CDC identified vitamin E acetate in illicit THC vaping cartridges as the primary cause of more than 2,800 hospitalizations and 68 deaths. The crisis peaked in September 2019. Paradoxically, the EVALI outbreak accelerated the decline in youth cannabis use. The 2019 YRBS showed past-30-day use at 21.7%, but the 2021 survey (delayed by COVID-19) recorded 15.8%—a 27% drop in two years. Public health researchers attributed the decline to heightened risk awareness, school closures that disrupted social networks where cannabis was shared, and the maturation of regulated markets with stricter age verification than illicit dealers.

2021-2026: The Legalization Era and Historic Lows

Between 2021 and 2026, 12 additional states legalized adult-use cannabis, bringing the total to 24 states plus Washington, D.C. and Guam. Medical programs expanded to 38 states. The total legal cannabis market reached $33.6 billion in 2025, according to BDSA analytics. During this period, youth use continued declining. The CDC's September 2026 YRBS release showed past-30-day use at 15.9% in 2025, the lowest rate since systematic monitoring began. The data reflected surveys of 17,232 high school students across all 50 states conducted between September 2024 and June 2025. Significantly, the decline was consistent across demographic groups. Use among Black students dropped from 25.5% in 2013 to 18.2% in 2025. Among Hispanic students, rates fell from 23.5% to 16.1%. White student use declined from 20.1% to 14.8%. The convergence of rates across racial groups occurred as criminal penalties for cannabis possession were eliminated in legal states, reducing the disproportionate impact on communities of color.

Key Players

Centers for Disease Control and Prevention

The CDC's Division of Adolescent and School Health administers the YRBS, the gold-standard survey for youth risk behaviors. The biennial survey has tracked cannabis use since 1991 with consistent methodology, allowing for reliable trend analysis. Dr. Kathleen Ethier, director of the division, said in September 2026 that the cannabis findings were "among the most striking positive trends we've seen in adolescent health in the past two decades." The CDC's data collection involves partnerships with state and local education agencies, with a response rate of 73% in the 2025 cycle.

National Institute on Drug Abuse

NIDA, part of the National Institutes of Health, funds the Monitoring the Future survey and dozens of research projects examining youth cannabis use. The agency's 2026 budget included $1.4 billion for cannabis research, with $89 million specifically allocated to adolescent use studies. NIDA Director Dr. Nora Volkow has emphasized that declining youth use does not mean cannabis is harmless, noting that the adolescent brain remains vulnerable to THC exposure through age 25. NIDA data shows that daily use among 12th graders, while rare, declined from 6.6% in 2011 to 2.5% in 2025.

NORML

The National Organization for the Reform of Marijuana Laws has advocated for legalization since 1970. NORML Deputy Director Paul Armentano said the CDC data "vindicates decades of advocacy" and demonstrates that "regulation works better than prohibition." The organization has consistently argued that legal markets with ID checks prevent youth access more effectively than illicit dealers. NORML's analysis of state-level data shows that 11 of the 12 earliest-legalizing states saw youth use decline or remain flat in the five years after retail sales began.

Smart Approaches to Marijuana

SAM, founded in 2013 by Kevin Sabet and former U.S. Representative Patrick Kennedy, opposes legalization and has cited youth protection as a primary concern. In response to the CDC data, SAM issued a statement questioning survey methodology and arguing that "today's high-potency products pose greater risks than the marijuana of previous decades, even if fewer kids are using." The organization pointed to emergency department visits involving adolescents and cannabis, which increased 23% between 2019 and 2024 according to the Healthcare Cost and Utilization Project, though total use declined.

Multi-State Operators

Large cannabis companies including Curaleaf, Trulieve, Green Thumb Industries, and Cresco Labs have invested in youth prevention as both a regulatory requirement and a public relations strategy. Curaleaf's "Don't Be a Lab Rat" campaign, launched in 2022, reached 2.3 million students in Massachusetts, New York, and New Jersey. The company's 2025 impact report claimed a 12% reduction in use intentions among program participants. Industry groups including the Cannabis Trade Federation have made youth prevention a lobbying priority, arguing that responsible operators deserve federal banking access and tax relief under 26 U.S.C. § 280E.

Drug Enforcement Administration

The DEA's position on youth use has evolved as the agency reviews cannabis scheduling. In a 2024 notice of proposed rulemaking (NPRM) to move cannabis from Schedule I to Schedule III, the agency acknowledged that "available data do not show increases in youth use correlated with state legalization." This represented a significant shift from the DEA's 2016 denial of a rescheduling petition, which cited youth protection as a reason to maintain Schedule I status. The agency's 2026 administrative law judge hearings on rescheduling included extensive testimony on youth use trends.

Legal and Regulatory Framework

Federal law prohibits cannabis for all ages under the Controlled Substances Act, but state-level legalization has created a patchwork of age restrictions, prevention mandates, and enforcement mechanisms that appear more effective at limiting youth access than federal prohibition. The Controlled Substances Act of 1970 (21 U.S.C. § 812) classifies cannabis as Schedule I, defined as having "no currently accepted medical use" and "high potential for abuse." This classification has remained unchanged for 56 years, though the DEA proposed rescheduling to Schedule III in 2024. Federal law sets no minimum age for cannabis offenses because all possession is prohibited. State medical marijuana laws typically set a minimum age of 18, with patients under 18 requiring parental consent and physician certification for qualifying conditions. As of 2026, 38 states have medical programs. Qualifying conditions for minors usually include epilepsy, cancer, and chronic pain, with some states limiting minors to low-THC, high-CBD products. Adult-use laws in 24 states set the minimum age at 21, matching the federal alcohol age under 21 U.S.C. § 158. Retail employees must verify age using government-issued ID, with penalties for selling to minors including license revocation, fines up to $100,000, and criminal charges. Point-of-sale systems in legal states flag transactions where ID verification was not recorded. State laws also mandate prevention funding. California's Proposition 64 (2016) allocates $10 million annually to the Department of Public Health for youth education programs. Colorado dedicates $12 million per year from cannabis tax revenue to evidence-based prevention in schools. Washington requires licensed retailers to display signage warning that cannabis is illegal for those under 21 and can harm the developing brain. The Preventing and Reducing Access to Children and Teens (PACT) Act, introduced in Congress in 2023 but not yet passed, would require federal prevention standards in any state with legal cannabis, including packaging restrictions, advertising limits, and mandatory retailer training.

State-by-State Breakdown

Youth cannabis use declined in 19 of the 24 adult-use states in the five years following legalization, with the steepest drops occurring in states with the most mature markets and robust prevention programs.

Colorado

Colorado legalized adult use in 2012 (Amendment 64), with retail sales beginning January 2014. Youth past-30-day use was 22% in 2011 and declined to 15.1% in 2025, according to the Healthy Kids Colorado Survey. The state's possession limit is one ounce for adults 21+. Colorado invested $145 million in youth prevention between 2014 and 2025, funding school-based programs and the "Good to Know" public education campaign. Key dates: November 2012 (voter approval), January 2014 (retail sales begin), July 2021 (delivery legalized).

Washington

Washington legalized adult use in 2012 (Initiative 502), with retail sales beginning July 2014. Youth use dropped from 20.4% in 2012 to 14.3% in 2025, per the Healthy Youth Survey. Possession limit: one ounce for adults 21+. The state allocated $8 million annually to prevention, including the "Parents 360" program targeting parents of middle schoolers. Key dates: November 2012 (voter approval), July 2014 (retail sales begin), March 2022 (social equity licenses issued).

California

California legalized adult use in 2016 (Proposition 64), with retail sales beginning January 2018. Youth use was 11.8% in 2017 and 10.2% in 2025, according to the California Healthy Kids Survey—the lowest rate of any large state. Possession limit: one ounce for adults 21+. California's prevention spending exceeded $50 million between 2018 and 2025, including the "Let's Talk Cannabis" parent education program. Key dates: November 2016 (voter approval), January 2018 (retail sales begin), September 2022 (statewide delivery approved).

Massachusetts

Massachusetts legalized adult use in 2016 (Question 4), with retail sales beginning November 2018. Youth use declined from 24.3% in 2017 to 16.8% in 2025, per the Youth Risk Behavior Survey. Possession limit: one ounce for adults 21+. The state's Cannabis Control Commission requires licensees to fund prevention programs, generating $18 million between 2019 and 2025. Key dates: November 2016 (voter approval), November 2018 (retail sales begin), May 2023 (social consumption sites approved).

Illinois

Illinois legalized adult use in 2019 (Cannabis Regulation and Tax Act), with retail sales beginning January 2020. Youth use was 18.9% in 2019 and 15.4% in 2025, according to the Illinois Youth Survey. Possession limit: 30 grams (approximately one ounce) for adults 21+. Illinois dedicated 20% of cannabis tax revenue to prevention, totaling $23 million through 2025. Key dates: June 2019 (legislative approval), January 2020 (retail sales begin), July 2023 (craft grow licenses issued).

New York

New York legalized adult use in 2021 (Marijuana Regulation and Taxation Act), with retail sales beginning December 2022. Youth use was 19.2% in 2021 and 17.1% in 2025, per the Youth Risk Behavior Survey. Possession limit: three ounces for adults 21+. The state allocated $20 million annually to prevention through the Office of Cannabis Management. Key dates: March 2021 (legislative approval), December 2022 (retail sales begin), April 2024 (on-site consumption approved).

States Without Legalization

Youth use also declined in non-legal states, though less dramatically. In Texas, where all cannabis remains illegal, youth use dropped from 20.8% in 2015 to 18.3% in 2025. In Alabama, rates fell from 19.4% to 17.9%. This suggests national factors—including changing youth attitudes, increased mental health awareness, and displacement of cannabis by other substances—contribute to the trend beyond legalization alone.

Market and Business Implications

The CDC data provides the cannabis industry with its most powerful rebuttal to federal prohibition, potentially accelerating rescheduling, banking access, and institutional investment by demonstrating that legal markets do not harm children. Multi-state operators have incorporated the youth use data into investor presentations and regulatory filings. Curaleaf's Q3 2026 earnings call highlighted the CDC findings as evidence that "responsible operators are good corporate citizens." The company's stock price increased 8% in the week following the data release. Trulieve, Green Thumb Industries, and Cresco Labs saw similar gains, with the MSOS cannabis ETF rising 12% between September 22 and September 29, 2026. The data strengthens the industry's case for federal reform. The Secure and Fair Enforcement (SAFE) Banking Act, which would allow financial institutions to serve cannabis businesses without federal penalty, has stalled in Congress partly due to concerns about youth access. Senate Banking Committee Chairman Sherrod Brown said in October 2026 that the CDC data "addresses one of my primary concerns" and suggested the bill could advance in the lame-duck session. Wholesale pricing dynamics may shift as the data encourages more states to legalize. BDSA analytics projects that six additional states will launch adult-use programs between 2027 and 2029, adding $8 billion in annual sales. Increased supply could pressure wholesale flower prices, which averaged $1,200 per pound in mature markets in 2026, down from $2,400 in 2020. Operators with efficient cultivation and strong retail brands will benefit from expansion, while smaller players may face consolidation pressure. Capital flows are responding. Private equity firms including Poseidon Asset Management and Merida Capital have raised $400 million in new funds since the CDC data release, citing reduced political risk. Public market valuations remain depressed—the MSOS ETF trades at 0.8x sales versus 2.5x for comparable consumer packaged goods companies—but institutional investors including Morgan Stanley and Goldman Sachs have initiated coverage of top MSOs for the first time. The data also impacts ancillary businesses. Compliance technology providers including Metrc and BioTrack have emphasized age verification features in marketing materials. Insurance companies offering product liability coverage have cited youth use trends in underwriting decisions, with some reducing premiums for retailers with robust ID-checking protocols.

What Experts Say

Public health researchers, policy analysts, and youth development specialists attribute the decline in adolescent cannabis use to a combination of regulated market controls, evidence-based prevention, and broader cultural shifts in youth substance use patterns. Dr. Rosalie Pacula, senior economist at the RAND Corporation and co-director of the RAND Drug Policy Research Center, said the data reflects "the success of age-restricted retail systems that don't exist in illicit markets." Her research, published in the Journal of Policy Analysis and Management in 2025, found that states with legal cannabis saw a 19% reduction in youth access compared to prohibition states, where any dealer willing to sell to adults will also sell to minors. Dr. Sharon Levy, director of the Adolescent Substance Use and Addiction Program at Boston Children's Hospital, emphasized that declining use does not eliminate risk. She noted that adolescents who do use cannabis are consuming higher-potency products, with average THC concentrations in flower reaching 25% in 2026 versus 13% in 2010. Her clinical experience shows that youth cannabis use disorder cases, while less common, are more severe when they occur. Dr. Beau Kilmer, director of the RAND Drug Policy Research Center, pointed to the "forbidden fruit" hypothesis. His team's analysis of 15 years of state-level data found that legalization reduced the perception of cannabis as rebellious, making it less appealing to adolescents. Survey data from the Monitoring the Future study shows that the percentage of 12th graders who view regular cannabis use as "great risk" declined from 52% in 2010 to 29% in 2025, yet actual use declined simultaneously—suggesting that risk perception alone does not drive behavior. Dr. Stanton Glantz, professor of medicine at the University of California, San Francisco, and tobacco control researcher, cautioned against complacency. He noted that cannabis industry marketing, while restricted, still reaches youth through social media and influencer partnerships. His analysis of Instagram and TikTok content found that 34% of cannabis-related posts were viewed by users under 21, despite platform age restrictions. Mason Tvert, former communications director for the Marijuana Policy Project and co-author of Colorado's Amendment 64, said the data validates the regulatory model his campaign promoted. He emphasized that legal states generate tax revenue for prevention—Colorado collected $423 million in cannabis taxes in 2025—while prohibition generates zero prevention funding and enriches criminal organizations. Dr. Kevin Sabet of SAM maintained that the data does not justify legalization, arguing that "we should be aiming for zero youth use, not celebrating that it's merely lower than before." He pointed to increases in youth cannabis-related emergency department visits and called for more research on long-term cognitive effects of adolescent use.

What's Next

The CDC's youth use data will influence three major policy decisions in the next 18 months: DEA rescheduling, state legalization campaigns, and federal legislation on banking and taxation. The DEA's administrative law judge hearings on rescheduling cannabis from Schedule I to Schedule III are scheduled to conclude in December 2026, with a final rule expected by June 2027. The youth use data will feature prominently in the record. If the DEA reschedules cannabis to Schedule III, businesses would gain access to normal tax deductions under 26 U.S.C. § 280E, potentially saving the industry $2 billion annually. However, Schedule III maintains federal prohibition for non-medical use, creating continued conflict with state adult-use laws. State legalization campaigns are underway in Florida, Ohio, Pennsylvania, and Oklahoma for 2027 ballot initiatives. Florida's Smart & Safe Florida campaign has already incorporated the CDC data into signature-gathering materials, arguing that "regulation protects kids better than prohibition." Polling shows 64% support for legalization in Florida, up from 58% before the CDC data release. Ohio's Coalition to Regulate Marijuana Like Alcohol is pursuing a statutory initiative after a 2023 ballot measure failed by 3 points. Federal banking legislation faces a critical window in the 2026 lame-duck congressional session. The SAFE Banking Act has passed the House seven times but stalled in the Senate. Senator Cory Booker, who previously opposed the bill without social equity provisions, said in October 2026 that he is "reassessing" his position in light of youth use data. If SAFE passes, cannabis businesses would gain access to traditional banking, credit cards, and capital markets, potentially adding $15 billion in institutional investment. The 2028 presidential election will shape federal policy. Both major parties are reassessing cannabis positions as youth use data undermines prohibition arguments. A bipartisan coalition in Congress is drafting comprehensive legalization legislation for introduction in 2027, modeled on the Cannabis Administration and Opportunity Act proposed in 2022 but never advanced. Research priorities are shifting toward understanding why youth use declined. NIDA's 2027 grant cycle includes $15 million for studies examining the mechanisms behind the trend, including surveys of adolescent attitudes, analysis of retail compliance data, and longitudinal studies of brain development in legal versus prohibition states.

Further Reading

• CDC Youth Risk Behavior Survey Data & Documentation: https://www.cdc.gov/healthyyouth/data/yrbs/index.htm
• Monitoring the Future Survey Results (University of Michigan): https://monitoringthefuture.org/
• RAND Drug Policy Research Center State Cannabis Legalization Analysis: https://www.rand.org/pubs/research_reports/RRA1722-1.html
• National Institute on Drug Abuse Cannabis Research Reports: https://nida.nih.gov/research-topics/cannabis-marijuana
• Colorado Department of Public Health Healthy Kids Colorado Survey: https://cdphe.colorado.gov/hkcs
• Washington State Healthy Youth Survey: https://www.doh.wa.gov/DataandStatisticalReports/DataSystems/HealthyYouthSurvey
• DEA Notice of Proposed Rulemaking on Cannabis Rescheduling (Federal Register Vol. 89, No. 95): https://www.federalregister.gov/
• NORML State-by-State Youth Use Analysis: https://norml.org/marijuana/fact-sheets/
• Smart Approaches to Marijuana Policy Positions: https://learnaboutsam.org/
• Cannabis Control Commission of Massachusetts Annual Reports: https://masscannabiscontrol.com/

Update — September 24, 2026: U.S. High School Cannabis Use Hits Historic Low

Cannabis use among U.S. high school students fell to its lowest level on record in 2026, according to newly released federal survey data. The decline continues a multi-year trend that began before the COVID-19 pandemic and has persisted despite the expansion of adult-use legalization across more than half of U.S. states. Past-30-day cannabis use among 12th graders dropped below 15 percent, marking the first time the rate has fallen beneath that threshold since systematic tracking began in the mid-1970s.

Public health researchers attributed the decline to sustained school-based prevention programs, reduced social acceptability of teen substance use, and stricter retail compliance enforcement in legal markets. States with regulated adult-use frameworks have implemented age-verification technology, mandatory ID scanning, and penalties for sales to minors that appear to have reduced youth access more effectively than prohibition-era enforcement. Survey respondents also reported that cannabis is harder to obtain now than five years ago, reversing concerns that legalization would increase adolescent availability.

The data counters longstanding arguments from legalization opponents who predicted that normalization of adult use would drive youth consumption upward. No state with a regulated market has seen a statistically significant increase in high school use rates since implementing legal sales, according to comparative analysis of state-level Youth Risk Behavior Surveillance System data. Colorado and Washington, the first states to launch adult-use programs in 2014, have both recorded declines exceeding 25 percent in teen past-month use over the past decade.

Industry stakeholders emphasized that the findings validate regulatory frameworks prioritizing youth protection through packaging restrictions, advertising bans near schools, and mandatory educational campaigns funded by excise taxes. However, researchers cautioned that vaping devices and high-potency concentrates require continued monitoring, as these products appeal disproportionately to younger demographics. Federal agencies have called for expanded research into long-term cognitive effects and the effectiveness of specific prevention strategies as legalization continues to expand nationwide.